Insider Shareholders with Direct Ownership of Chimerix Inc (CMRX)
This section provides a comprehensive overview of the insiders with direct ownership of Chimerix Inc (CMRX). You can find detailed information about the size and nature of each insider's ownership stake, as well as the latest updates on their holdings.
CHIMERIX INC Insider List
| Insider | Adquired | Disposed | Held | # of Trades | Last Transaction |
|---|---|---|---|---|---|
|
Cantex Pharmaceuticals, Inc.
> 10% Shareholder |
0 | 6,500,000 | 3,500,000 $14.5 Million | 1 |
Sep 14, 2021
Reduced 65.0%
|
|
Michael T. Andriole
PRESIDENT AND CEO |
407,625 | 20,029 | 619,323 $2.56 Million | 10 |
Jan 07, 2025
Added 19.5%
|
|
Michael A. Sherman
Chief Executive Officer |
192,950 | 0 | 222,995 $920,969 | 2 |
Jan 17, 2023
Added 29.42%
|
|
Michael Albert Alrutz
SVP AND GENERAL COUNSEL |
84,992 | 0 | 215,196 $888,759 | 3 |
Jan 07, 2025
Added 16.22%
|
| 10,000 | 0 | 207,523 $857,069 | 2 |
Jun 28, 2021
Added 3.24%
|
|
|
Michelle La Spaluto
CHIEF FINANCIAL OFFICER |
66,667 | 1,940 | 176,252 $727,920 | 3 |
Jan 07, 2025
Added 19.12%
|
|
Allen S. Melemed
CHIEF MEDICAL OFFICER |
99,790 | 0 | 155,940 $644,032 | 3 |
Jan 07, 2025
Added 22.75%
|
|
David Jakeman
VP OF FINANCE AND ACCOUNTING |
69,205 | 30,555 | 152,087 $628,119 | 15 |
Jan 07, 2025
Added 6.66%
|
|
Thomas J Riga
COO and CCO |
54,275 | 0 | 57,501 $237,479 | 1 |
Jan 07, 2025
Added 48.56%
|
| 21,650 | 0 | 35,150 $145,169 | 3 |
May 08, 2023
Added 19.93%
|
|
| 7,042 | 7,042 | 0 $0 | 2 |
Nov 17, 2020
Reduced 100.0%
|